Morgan Stanley’s Sutro Biopharma STRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$185K Buy
258,595
+62,735
+32% +$44.8K ﹤0.01% 5886
2025
Q1
$127K Sell
195,860
-1,324,276
-87% -$862K ﹤0.01% 5910
2024
Q4
$2.8M Buy
1,520,136
+1,246,051
+455% +$2.29M ﹤0.01% 4453
2024
Q3
$948K Sell
274,085
-13,725
-5% -$47.5K ﹤0.01% 5074
2024
Q2
$843K Sell
287,810
-261,556
-48% -$766K ﹤0.01% 5062
2024
Q1
$3.1M Buy
549,366
+101,518
+23% +$574K ﹤0.01% 4293
2023
Q4
$1.92M Buy
447,848
+294,593
+192% +$1.26M ﹤0.01% 4949
2023
Q3
$532K Sell
153,255
-36,341
-19% -$126K ﹤0.01% 5142
2023
Q2
$882K Buy
189,596
+45,178
+31% +$210K ﹤0.01% 4905
2023
Q1
$667K Sell
144,418
-83,509
-37% -$386K ﹤0.01% 5091
2022
Q4
$1.84M Sell
227,927
-103,646
-31% -$837K ﹤0.01% 4519
2022
Q3
$1.84M Sell
331,573
-533
-0.2% -$2.96K ﹤0.01% 4498
2022
Q2
$1.73M Sell
332,106
-7,080
-2% -$36.9K ﹤0.01% 4645
2022
Q1
$2.79M Buy
339,186
+275,689
+434% +$2.27M ﹤0.01% 4258
2021
Q4
$946K Buy
63,497
+37,354
+143% +$557K ﹤0.01% 5109
2021
Q3
$493K Sell
26,143
-167,035
-86% -$3.15M ﹤0.01% 5506
2021
Q2
$3.59M Sell
193,178
-579,928
-75% -$10.8M ﹤0.01% 4118
2021
Q1
$17.6M Buy
773,106
+641,486
+487% +$14.6M ﹤0.01% 2045
2020
Q4
$2.86M Buy
131,620
+121,315
+1,177% +$2.63M ﹤0.01% 3841
2020
Q3
$103K Buy
10,305
+4,410
+75% +$44.1K ﹤0.01% 5423
2020
Q2
$46K Buy
5,895
+5,054
+601% +$39.4K ﹤0.01% 5704
2020
Q1
$9K Sell
841
-16,761
-95% -$179K ﹤0.01% 6048
2019
Q4
$194K Sell
17,602
-6,440
-27% -$71K ﹤0.01% 5424
2019
Q3
$219K Buy
24,042
+23,220
+2,825% +$212K ﹤0.01% 5083
2019
Q2
$9K Sell
822
-156
-16% -$1.71K ﹤0.01% 6169
2019
Q1
$11K Sell
978
-8,819
-90% -$99.2K ﹤0.01% 6159
2018
Q4
$88K Buy
+9,797
New +$88K ﹤0.01% 5599